OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
πΊπΈUnited States
Aripiprazole Open-Label, Safety and Tolerability Study
- First Posted Date
- 2005-01-31
- Last Posted Date
- 2012-08-31
- Target Recruit Count
- 325
- Registration Number
- NCT00102518
- Locations
- πΊπΈ
Local Institution, Wauwatosa, Wisconsin, United States
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
Phase 2
Completed
- Conditions
- SchizophreniaMania
Aripiprazole in Adolescents With Schizophrenia
Phase 3
Completed
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2005-01-20
- Last Posted Date
- 2012-08-10
- Target Recruit Count
- 302
- Registration Number
- NCT00102063
- Locations
- π΅π·
Local Institution, San Juan, Puerto Rico
Aripiprazole Oral Acceptability Trial
- First Posted Date
- 2005-01-13
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 59
- Registration Number
- NCT00101569
- Locations
- πΊπΈ
Local Institution, Falls Church, Virginia, United States
Study of Aripiprazole in Patients With Acute Bipolar Mania
Phase 3
Completed
- Conditions
- Bipolar Disorder
- Interventions
- First Posted Date
- 2004-11-22
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 615
- Registration Number
- NCT00097266
- Locations
- πΏπ¦
Local Institution, Berea, Kwa Zuluu Natal, South Africa
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2013-11-11
- Target Recruit Count
- 125
- Registration Number
- NCT00095719
- Locations
- πΊπΈ
Local Institution, Midvale, Utah, United States
Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 50
- Registration Number
- NCT00095810
- Locations
- πΊπΈ
Local Institution, Albany, New York, United States
A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2013-11-08
- Target Recruit Count
- 1002
- Registration Number
- NCT00095745
- Locations
- πΊπΈ
Local Institution, Middleton, Wisconsin, United States
Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
Phase 3
Completed
- Conditions
- Psychotic DisorderBody Weight ChangeSchizophreniaSchizoaffective Disorder
- First Posted Date
- 2004-11-08
- Last Posted Date
- 2013-11-11
- Target Recruit Count
- 300
- Registration Number
- NCT00095524
- Locations
- π¬π§
Local Institution, Birmingham, West Midlands, United Kingdom
Aripiprazole in Patients With Acute Mania
Phase 3
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2004-11-08
- Last Posted Date
- 2013-11-11
- Target Recruit Count
- 615
- Registration Number
- NCT00095511
- Locations
- πΊπΈ
Local Institution, Arlington, Virginia, United States
πΊπΈLocal Institition, Shreveport, Louisiana, United States
Β© Copyright 2025. All Rights Reserved by MedPath